» Articles » PMID: 11333294

Serum Hormones and the Alcohol-breast Cancer Association in Postmenopausal Women

Overview
Specialty Oncology
Date 2001 May 3
PMID 11333294
Citations 94
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Alcohol ingestion is associated with an increased risk of breast cancer in most epidemiologic studies. Results, however, are heterogeneous at lower levels of alcohol intake, and a biologic mechanism for the association has not been clearly identified. To determine whether alcohol consumption by postmenopausal women elevates serum levels of hormones associated with an increased risk of breast cancer, we performed a controlled feeding study.

Methods: Participants were 51 healthy postmenopausal women not using hormone replacement therapy. Each participant rotated through three 8-week dietary periods in which she consumed 15 or 30 g of alcohol per day or an alcohol-free placebo beverage. The order of assignment to the three alcohol levels was random. During the dietary periods, all food and beverages were supplied by the study, and energy intake was adjusted to keep body weight constant. Levels of estradiol, estrone, estrone sulfate, testosterone, androstenedione, progesterone, dehydroepiandrosterone (DHEA), DHEA sulfate (DHEAS), and androstenediol were measured by radioimmunoassays in serum collected at the end of each dietary period. All statistical tests are two-sided.

Results: When women consumed 15 or 30 g of alcohol per day, respectively, estrone sulfate concentrations increased by 7.5% (95% confidence interval [CI] = -0.3% to 15.9%; P =.06) and 10.7% (95% CI = 2.7% to 19.3%; P =.009) and DHEAS concentrations increased by 5.1% (95% CI = 1.4% to 9.0%; P =.008) and 7.5% (95% CI = 3.7% to 11.5%; P<.001) relative to levels when women consumed placebo. None of the other hormones measured changed statistically significantly when women consumed alcohol.

Conclusions: Results suggest a possible mechanism by which consumption of one or two alcoholic drinks per day by postmenopausal women could increase their risk of breast cancer.

Citing Articles

Unveiling the effect of estrogen receptors in alcoholic liver disease: A novel outlook.

Baweja S, Mittal A, Thangariyal S, Debishree Subudhi P, Gautam S, Kaul R Liver Res. 2025; 7(4):333-341.

PMID: 39958778 PMC: 11791908. DOI: 10.1016/j.livres.2023.10.002.


Effect of daily alcohol intake on sex hormone levels among postmenopausal breast cancer survivors on aromatase inhibitor therapy: a randomized controlled crossover pilot study.

Mostofsky E, Buring J, Come S, Tung N, Zhang C, Mukamal K Breast Cancer Res. 2025; 27(1):5.

PMID: 39789640 PMC: 11720806. DOI: 10.1186/s13058-024-01940-4.


Fezolinetant treatment of moderate-to-severe vasomotor symptoms due to menopause: effect of intrinsic and extrinsic factors in two phase 3 studies (SKYLIGHT 1 and 2).

Santoro N, Nappi R, Neal-Perry G, English M, King D, Yamaguchi Y Menopause. 2024; 31(4):247-257.

PMID: 38517210 PMC: 11896090. DOI: 10.1097/GME.0000000000002340.


The role of neurosteroids in posttraumatic stress disorder and alcohol use disorder: A review of 10 years of clinical literature and treatment implications.

Peltier M, Verplaetse T, Altemus M, Zakiniaeiz Y, Ralevski E, Mineur Y Front Neuroendocrinol. 2024; 73:101119.

PMID: 38184208 PMC: 11185997. DOI: 10.1016/j.yfrne.2023.101119.


Alcohol consumption and prognosis and survival in breast cancer survivors: The Pathways Study.

Kwan M, Valice E, Ergas I, Roh J, Caan B, Cespedes Feliciano E Cancer. 2023; 129(24):3938-3951.

PMID: 37555890 PMC: 10840903. DOI: 10.1002/cncr.34972.